This paper published with several formatting errors. They have been corrected and the paper has re-published.doi:10.1007/s11606-019-05408-6Emily H. JungAmeet SarpatwariAaron S. KesselheimMichael S. SinhaSpringer International PublishingJournal of General Internal Medicine...
The approvalof this medicinedeveloped and manufactured by Henlius, is a significant milestone for both companies. Zercepac® is the first monoclonal antibody (mAb), and third biosimilar, launched by Accord inEurope, and it is the first mAb developed by Henlius to ...
doi:10.1038/nrd4096AnonymousNature Reviews Drug DiscoveryEMA backs approval of first biosimilar monoclonal antibodies. Nat Rev Drug Discov 12: 568.